US FDA New Clinical for Sense Neuro Diagnostic
The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices will begin as soon as June 2023 and involve up to 300 patients at 30 sites in the United States, as well as Canada and India.
St. Elizabeth Healthcare Invests $250,000 In Sense Neuro Diagnostics
Medical technology startup Sense Neuro Diagnostics has received $250,000 in funding from St. Elizabeth Healthcare in Edgewood, Kentucky. The investment will help Sense Neuro Diagnostics as the company advances clinical trials in its effort to commercialize a non-invasive technology to monitor traumatic brain injuries.
Sense Neuro Diagnostics Awarded Arizona Innovation Challenge
Sense Neuro Diagnostics is getting ready to participate in the Arizona Commerce Authority Venture Ready Accelerator, an initiative that helps startups refine business plans, improve go-to-market execution strategies, and increase investor readiness.
Sense Neuro Diagnostics Places Second In Unicorn Cup Finals Q4 2022
Cincinnati-based Sense Neuro Diagnostics is pursuing new international investment opportunities after coming in second place in the Unicorn CUP Finals startup competition. The pitch event is affiliated with Unicorn Events, the world’s largest startup pitch competition that focuses on discovering extraordinary startups that have the potential to achieve a valuation of $1 billion or more.
Sense Diagnostics Awarded $25,000 Prize at Defense TechConnect (DTC) Innovation Summit & Expo
Sense Diagnostics was recently recognized as one of seven winners of the 2022 Medical Innovation Challenge at the Defense TechConnect (DTC) Innovation Summit & Expo, the nation’s largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.
Sense Neuro Diagnostics Participates in Mayo Clinic and ASU MedTech Accelerator
Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, has been selected to participate in the Mayo Clinic and Arizona State University MedTech Accelerator.
Sense Neuro Diagnostics lands $250,000 equity investment from St. Elizabeth Healthcare
Cincinnati Business Courier
March 20, 2023
NFL Legend Joins Renowned Professors and Innovators to Tackle Traumatic Brain Injury at LSI USA '23
March 15, 2023
Sense Neuro adds second office in Phoenix after landing Mayo Clinic agreement
January 25, 2023
Sense Diagnostics inks 'know-how' license agreement with Mayo Clinic
December 14, 2022
MedCity INVEST Pitch Perfect Winners
July 20-24 2020. Virtual Conference.
The Sensor Evaluation of Neurologic Status in Emergencies (SENSE) Device
American College of Emergency Physicians
Cincinnati brain injury startup nabs $1.3M investment from Queen City Angels
Cincinnati Business Courier
Mar 16, 2017
'Time is brain': Startup Sense Diagnostics races to develop technology to save cognitive function
Oct 15, 2016